Comparison
Tretinoin vs. GHK-Cu (Copper Tripeptide)
Tretinoin or GHK-Cu – what really works against wrinkles?
The short answer
For photoaged skin, tretinoin carries considerably more weight. Blinded studies run up to two years; after 24 weeks the skin improved in 68 percent versus 43 percent with vehicle cream, and tissue samples show a rising marker of new collagen formation. According to the US approval, though, it does not remove deep wrinkles. GHK-Cu is strong preclinically but thinly supported in humans: the best study concerns diabetic foot ulcers, the 12-week cosmetic studies are mostly conference abstracts or industry reports, and there are no human data on injection. The two stood side by side only in one small biopsy study with collagen as the endpoint. Tretinoin is prescription-only in Germany, not approved for skin ageing there and contraindicated in pregnancy; the decision belongs with a doctor.
The numbers side by side
| Axis | Tretinoin | GHK-Cu (Copper Tripeptide) | Difference |
|---|---|---|---|
| Human evidenceHow much and how good the data in humans are | 8 | 4 | Tretinoin better studied |
| MechanismHow well the chain of action is understood | 8 | 7 | Tretinoin better studied |
| Safety dataHow well safety has been studied – not how safe it is | 8 | 6 | Tretinoin better studied |
| Hype gap10 means: the advertising stays level with the data | 5 | 4 | Tretinoin closer to the data |
| Track record of useHow much documented use in humans exists – does not measure whether it works | 9 | 5 | Tretinoin in use longer |
| Rating | Well supported, heavily overhyped · Thin human evidence | ||
“Track record of use” measures how long and how widely something has been used in humans – not whether it works. The BK-Score is a subjective assessment by Biohacking Kompakt based on published scoring rules (German). It is not a scientific rating, not the consensus of a professional society and not a medical recommendation.
Why these numbers
Tretinoin
Evidence 8, because the effect against acne has been placed in a network meta-analysis of 221 randomized studies (Huang 2023) and the effect against photoaging has been measured in blinded studies of up to two years – after 24 weeks the skin improved in 68 percent with 0.05 % cream versus 43 percent with vehicle cream (Olsen 1992). Mechanism 8, because the action via retinoic acid receptors and the changes in human tissue samples have been described, up to a rising marker of new collagen formation (Kang 2005). Safety 8, because the skin irritation is known from decades of use and the pregnancy risk was reviewed at European level in 2018; the axis rates the data, not the danger. Hype 5, because tretinoin is marketed as a rejuvenating agent, but the US approval states explicitly that it does not eliminate wrinkles or reverse skin ageing, and many participants also saw an improvement with vehicle cream. Use 9, because tretinoin has been used against acne for decades. Direction positive: the data support the effect against acne and fine wrinkles, to a smaller extent than advertising suggests.
GHK-Cu (Copper Tripeptide)
A split case. In humans there is one randomized study with blinded assessment on diabetic foot ulcers showing markedly better wound closure (Mulder 1994: median 98.5 versus 60.8 percent) and several small cosmetic studies over 12 weeks in women around 50, which, however, are mostly available as conference abstracts or industry reports. Systematic reviews from 2026 rate the human literature as thin and fragmentary; a small study after laser treatment was negative on objective endpoints. For injected use there are no human data; the FDA points to limited data and an immune risk. The gene-regulation narrative stems from cell-line databases and is used for both routes of application.
Frequently asked questions
Is GHK-Cu stronger than tretinoin?
The data do not allow that conclusion. In a small biopsy study, collagen increased after one month in 70 percent of women using GHK-Cu, 50 percent using vitamin C and 40 percent using retinoic acid, that is, tretinoin. That is a tissue marker after a short time, not a visible effect on wrinkles, and the sources do not give the number of participants. For visible fine wrinkles, tretinoin has blinded studies of up to two years, GHK-Cu small 12-week studies that mostly did not appear in journals.
Does a GHK-Cu injection do more than tretinoin cream?
That has not been studied. There is not a single human study on GHK-Cu injection, neither on efficacy nor on safety; the idea of a whole-body effect rests on animal experiments. The FDA points to limited data and a possible immune risk. A not yet peer-reviewed analysis of 6441 grey-market samples from 14 peptides, including GHK-Cu, found quality defects in 41.6 to 71.1 percent and endotoxin in 15 percent. Tretinoin, by contrast, is applied to the skin and has been studied for that use for decades.
What side effects do tretinoin and GHK-Cu have?
With tretinoin, redness, peeling, burning, dryness and itching are common, especially at the start, and the skin becomes more sensitive to light. It is contraindicated in pregnancy and when planning a pregnancy, as a European review procedure established in 2018. GHK-Cu has been used on the skin in cosmetics for decades without a documented cluster of serious side effects, but systematic safety studies are lacking. People with Wilson's disease should avoid additional sources of copper, and there are no data on pregnancy and breastfeeding.
Are tretinoin and GHK-Cu freely available?
Tretinoin is prescription-only in Germany and approved as a cream for acne vulgaris. There is no approval for skin ageing there, so using it for that is off-label; in the USA a cream is approved as an adjunct against fine facial wrinkles. GHK-Cu is freely marketable as a cosmetic ingredient in the EU and is found in many serums and creams. It is not approved as a medicine anywhere, and injectable product is sold as a research peptide.
See all ratings in the ranking (German app)
Information only, not medical advice and not a usage or dosage recommendation. Prescription-only and unapproved substances belong in a doctor's hands.